Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target

Characterization of Fibroblast Growth Factor Receptor 1 in Small-Cell Lung Cancer

(2014) Anish Thomas et al.   Journal of Thoracic Oncology

Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma

(2014) Hiroshi Yoshida et al.   VIRCHOWS ARCHIV

Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions

(2013) Sandra Schmitz et al.   CANCER TREATMENT REVIEWS

Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma

(2013) Nils C Lehnen et al.   HISTOPATHOLOGY

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity

(2013) Wedad M Hanna et al.   MODERN PATHOLOGY

Targeted Therapy for Orbital and Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma

(2013) Vivian T. Yin et al.   OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY

Targeting Epidermal Growth Factor Receptor in the Management of Lung Cancer

(2013) Tony S.K. Mok et al.   SEMINARS IN ONCOLOGY

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

(2012) Libero Santarpia et al.   BREAST CANCER RESEARCH AND TREATMENT

Role of epidermal growth factor receptor in breast cancer

(2012) Hiroko Masuda et al.   BREAST CANCER RESEARCH AND TREATMENT

A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck

(2012) Carol M. Lewis et al.   CLINICAL CANCER RESEARCH

Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer

(2012) Hye Ryun Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

(2012) Hans-Ulrich Schildhaus et al.   MODERN PATHOLOGY

HER2 testing in gastric cancer: a practical approach

(2012) Josef Rüschoff et al.   MODERN PATHOLOGY

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

(2011) Vicki Leigh Keedy et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel Therapeutic Targets in Non-small Cell Lung Cancer

(2011) Filip Janku et al.   Journal of Thoracic Oncology

An overview of the c-MET signaling pathway

(2011) Shawna Leslie Organ et al.   Therapeutic Advances in Medical Oncology

IncreasedMETGene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

(2009) Federico Cappuzzo et al.   JOURNAL OF CLINICAL ONCOLOGY

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

(2009) M Varella-Garcia et al.   JOURNAL OF CLINICAL PATHOLOGY

Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma

(2009) Doina Ivan et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Sebaceous carcinoma: the great masquerader

(2008) William Buitrago et al.   Dermatologic Therapy

Sebaceous Cell Carcinoma of the Ocular Adnexa: Clinical Presentations, Histopathology, and Outcomes

(2008) Alice Song et al.   OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY